Pfizer beats forecasts as oncology drugs grow
July 29, 2014 at 07:33 AM EDT
(Reuters) - Pfizer Inc , which in May officially abandoned its bid to buy British rival AstraZeneca Plc , reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.